Dana-Farber Cancer Institute, Site 008

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia (CML), GIST, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Studies at this site

• A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor — Completed
• Expanded Access Program of Ponatinib — APPROVED_FOR_MARKETING
• Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) — Stopped early